BEST UNLIMITED TURBO LONG CERTIFICATE - PFIZER INC | Market Closed - Euronext Paris 10:00:00 31/05/2024 pm IST | ||
| 10.15 EUR | +5.23% |
|
| 1 month | +33.04% | ||
| 3 months | +16.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 10.15 | +5.23% |
| 30/24/30 | 9.647 | +0.95% |
| 29/24/29 | 9.556 | -3.89% |
| 28/24/28 | 9.943 | -6.09% |
| 27/24/27 | 10.59 | +3.11% |
Real-time Euronext Paris
Last update May 31, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| OB21S | |
| ISIN | DE000SU5PYC6 |
| Date issued | 13/12/2023 |
| Strike | 17.58 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.74 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.91 € |
|---|---|
| Lowest since issue | 7.259 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- OB21S Certificat
